Successful manufacture of amoeba vaccine after 20 years of research

After 20 years of research, the team of scientists from Mexico Autonomous University of Aguascalientes (UAA) has successfully prepared a recombinant vaccine capable of boosting the immune system against the single-celled Entomoeba histolytica. amoeba caused by amoeba.

According to a reporter in Mexico, Professor Javier Ventura Juárez, one of the members of the research team, said that although amoeba is not yet considered a serious disease, it affects 40% of the world's population, especially especially the poor. To prevent this disease requires a variety of protection mechanisms such as the use of clean water and good nutrition.

Single cell Entamoeba histolytica.(Source: wikipedia.org).

Although the human body is protected by the immune system against parasites, Entomoeba histolytica protozoa are still very easy to penetrate. Entomoeba histolytica causes diarrhea and stomach pain. Without early detection will cause dangerous complications.

According to Professor Ventura Juárez, the new vaccine gave good results after preclinical tests and was able to destroy or limit the development of some other pathogenic bacteria.

The new vaccine will be clinically tested to assess the level of biosecurity, then apply for a certificate from the World Health Organization (WHO) and the next step is to apply it on the human body.

Amoeba histolytica is a single-celled disease caused by amoeba, a disease that typically causes ulcers in the lining of the colon and is capable of causing infections in different organs (liver, brain .). The disease tends to be prolonged and chronic if not treated aggressively.

About 90% of cases of amoeba infection have no obvious symptoms.